FDA approves first Biosmiliar drug Zarxio to lighten the chemotherapy effects

March 8, 2015 10:21 AM

13 0

The nation’s first biosimilar drug, Zarxio, has been approved by the U.S. Food And Drug Administration. It is a move that has been embraced positively by many Americans citing that it would lead to more affordable medication and especially to those who use the cutting-edge biologic drugs.

Biologic drugs are said to be innovative and into more use by the cancer patients and those with rheumatoid arthritis. Cancer patient always experience low levels of white blood cells and these drugs come in handy in managing the situation.

Read more

To category page